Molina (MOH) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 23. On the oth ...

Health insurer Elevance Health Inc. ELV is scheduled to release its second quarter 2025 financial results on July 17.Analysts estimate adjusted earnings of $9.197 per share on sales of $48.24 billion, as per data from Benzinga Pro.UnitedHealth Group Inc. UNH has been the first major health insurer to report quarterly earnings for several quarters. However, this quarter, the insurance giant will release its second quarter 2025 financial results on July 29.As it’s the biggest player in the industry, Forbes wr ...

Core Insights - Molina Healthcare, Inc. has reduced its full-year 2025 earnings guidance by 10.2% at mid-point due to rising medical costs and unpredictable utilization trends, following Centene Corporation's withdrawal of its financial outlook [1][3][10] Group 1: Earnings Guidance and Financial Outlook - For Q2 2025, Molina expects adjusted earnings of approximately $5.50 per share, which is below the Zacks Consensus Estimate of $6.12 per share and represents a 6.1% decline year-over-year [4] - The full-year adjusted earnings per share is now projected to be between $21.50 and $22.50, a significant drop from the previous forecast of at least $24.50 and below last year's figure of $22.65 [4][10] - The Zacks Consensus Estimate for Molina's 2025 revenue stands at $44.1 billion, indicating an 8.4% increase from the prior year, suggesting robust demand despite cost pressures [5] Group 2: Industry Context and Comparisons - Molina is part of a trend among health insurers facing unexpected cost pressures, with UnitedHealth Group and Centene also having withdrawn their earnings guidance [3][10] - Molina's shares have declined by 31.6% over the past three months, while the industry has dropped 38.9%, with UnitedHealth and Centene experiencing even steeper losses of 47.5% and 47.3%, respectively [9][10] Group 3: Long-term Outlook and Valuation - Despite the current challenges, Molina's long-term strategic outlook remains unchanged, with the CEO expressing confidence in the company's fundamentals [8] - Molina trades at a forward price-to-earnings ratio of 8.85, which is lower than the industry average of 11.66, and currently holds a Value Score of A [13]

Molina Healthcare reduced its full-year profit expectations as CEO Joseph Zubretsky pointed to rising costs that have outpaced insurance premiums. https://t.co/SZpZm2aguP ...

Core Viewpoint - The article emphasizes the importance of value investing and highlights Molina Healthcare (MOH) as a strong candidate for value investors due to its favorable financial metrics and Zacks Rank [2][4][6]. Company Analysis - Molina Healthcare (MOH) currently holds a Zacks Rank of 2 (Buy) and an A grade for Value, indicating strong potential for value investors [4]. - The stock has a Forward P/E ratio of 9.13, significantly lower than the industry average of 11.67, suggesting it may be undervalued [4]. - Over the past year, MOH's Forward P/E has fluctuated between a high of 14.07 and a low of 9.11, with a median of 12.14, indicating volatility but also potential for recovery [4]. - The PEG ratio for MOH is 0.75, compared to the industry average of 1.09, further supporting the notion that the stock is undervalued relative to its expected earnings growth [5]. - MOH's PEG ratio has ranged from a high of 1.24 to a low of 0.75 over the past year, with a median of 1.00, reflecting its growth potential [5]. - The combination of these metrics suggests that MOH is an impressive value stock at the moment, bolstered by a strong earnings outlook [6].

News Release Investor Contact: Jeffrey Geyer, Jeffrey.Geyer@molinahealthcare.com, 305-317-3012 Media Contact: Caroline Zubieta, Caroline.Zubieta@molinahealthcare.com, 562-951-1588 Molina Healthcare Announces Preliminary Second Quarter Financial Results and Updates Fiscal Year 2025 Earnings Per Share Guidance Long Beach, Calif., July 7, 2025 – Molina Healthcare, Inc. (NYSE: MOH) today announced preliminary financial results for the second quarter of 2025 and updated its full year 2025 adjusted earnings per s ...

Core Viewpoint - Molina (MOH) has experienced significant selling pressure, resulting in an 18.3% decline over the past four weeks, but analysts anticipate better earnings than previously expected, indicating potential for recovery [1] Group 1: Technical Analysis - The Relative Strength Index (RSI) is a momentum oscillator that helps identify whether a stock is oversold, with readings below 30 indicating oversold conditions [2] - MOH's current RSI reading of 21.88 suggests that the heavy selling may be exhausting, indicating a potential bounce back towards equilibrium in supply and demand [5] Group 2: Fundamental Analysis - There is a strong consensus among sell-side analysts to raise earnings estimates for MOH, with the consensus EPS estimate remaining unchanged over the last 30 days, which typically correlates with price appreciation [7] - MOH holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the potential for a near-term turnaround [8]

Market Overview - Markets ended higher on Wednesday, with the S&P 500 and Nasdaq Composite indices advancing by 0.47% and 0.94%, respectively, while the Dow Jones Industrial Average dropped by 10.52 points [1] - Market sentiment was positively influenced by a trade accord between the United States and Vietnam, easing concerns over prolonged trade tensions [1] Economic Indicators - A recent ADP report indicated an unexpected drop in private payrolls for June, with the private sector losing 33,000 jobs, suggesting potential challenges for the U.S. economy [2] - This decline in job numbers has raised scrutiny from investors, particularly in light of the Federal Reserve's cautious stance on interest rates [2] Investment Strategy - In the current macroeconomic environment, focusing on companies with strong financial fundamentals is crucial [3] - Relying solely on sales and earnings metrics may not yield long-term returns; a deeper analysis of a company's financial health and stability is essential for sustainable investment growth [3] Financial Analysis - A critical analysis of a company's financial background, including coverage ratios, is necessary for informed investment decisions [4] - The Interest Coverage Ratio is a key indicator used to evaluate a company's ability to pay interest on its debt, ensuring it is not over-leveraged [4][6] Interest Coverage Ratio Insights - The Interest Coverage Ratio is calculated as Earnings before Interest & Taxes (EBIT) divided by Interest Expense [5] - A ratio lower than 1.0 indicates a company may struggle to meet its interest obligations, while a higher ratio suggests a stronger financial position [9] Company Performance - Hudbay Minerals Inc. (HBM), Sterling Infrastructure, Inc. (STRL), Molina Healthcare, Inc. (MOH), and Vertiv Holdings Co (VRT) have strong interest coverage ratios, indicating solid financial footing [10] - HBM and STRL posted over 40% EPS growth estimates, while VRT shows a growth potential of 24.9% [10] - MOH projects 8.4% sales growth and 7.9% EPS growth, despite a 19.3% stock decline over the past year [10] Stock Screening Criteria - Stocks should have an Interest Coverage Ratio greater than the industry average, a favorable Zacks Rank, and a VGM Score of A or B for better investment results [11] - Additional criteria include a minimum stock price of $5, strong historical and projected EPS growth, substantial trading volume, and a Zacks Rank of 1 or 2 [12][13] Company Highlights - Hudbay Minerals has a trailing four-quarter earnings surprise of 50% on average, with a Zacks Consensus Estimate suggesting growth of 9.2% in sales and 41.7% in EPS [14] - Sterling Infrastructure has a trailing four-quarter earnings surprise of 11.5% on average, with a projected EPS growth of 41.2% [15] - Molina Healthcare's Zacks Consensus Estimate indicates growth of 8.4% in sales and 7.9% in EPS [16] - Vertiv Holdings has a trailing four-quarter earnings surprise of 10.4% on average, with projected growth of 18.8% in sales and 24.9% in EPS [17]

Group 1 - The Senate's rules committee recently rejected a key provision of the "grand plan" pushed by the Trump administration, which aimed to limit states from obtaining federal funds through taxes on Medicaid service providers [1] - The proposed provision sought to freeze the long-standing tax mechanism used by 49 states to collect taxes from hospitals and clinics providing Medicaid services, with the Senate version suggesting more aggressive adjustments to significantly reduce such tax scales [1] - The ruling from the Senate rules committee represents a significant setback for the legislative process of this controversial provision, as it is rare for the Senate to overturn the committee's decisions [1] Group 2 - The policy battle has significant implications for the U.S. health insurance industry, with stocks of companies deeply involved in Medicaid programs, such as Centene and Molina Healthcare, experiencing increases following the Senate's ruling [2] - National comprehensive insurers like UnitedHealth and Humana, as well as integrated healthcare groups like CVS Health and Cigna, also saw their stock prices rise in response to the news [2]

Core Insights - Molina Healthcare, Inc. (MOH) is a multi-state managed care organization providing healthcare services under Medicaid and Medicare programs, with a stock performance of +1.5% year-to-date against an industry decline of -28.4% [1][2] Company Overview - Headquartered in Long Beach, CA, MOH has a market capitalization of $16 billion and focuses on affordable health insurance plans for lower-income individuals and families [2] - The trailing 12-month P/E ratio is 12.84X, higher than the industry average of 10.79X, indicating growing investor confidence [2] - MOH currently holds a Zacks Rank 2 (Buy) [2] Financial Estimates - The Zacks Consensus Estimate for MOH's 2025 earnings is $24.44 per share, reflecting a 7.9% year-over-year increase [3] - Revenue estimates for 2025 are projected at $44.1 billion, with the company beating earnings estimates in three of the past four quarters [3] Growth Drivers - MOH's premium revenues grew by 11.8% year-over-year to $10.6 billion in Q1 2025, with expectations of a 9% increase in 2025, targeting around $42 billion [4][9] - Total membership increased by 0.4% year-over-year to approximately 5.8 million, with projections of reaching 5.9 million in 2025, a 7.3% increase from 2024 [5][9] - The company secured a new contract for a Fully Integrated Dual Eligible Special Needs Plan (D-SNP) in Illinois, enhancing its service offerings [6] Financial Metrics - MOH's return on equity stands at 28.4%, surpassing the industry average of 24%, indicating effective utilization of shareholder funds [7] - The balance sheet shows cash and cash equivalents of $4.9 billion compared to long-term debt of $3.6 billion, providing financial flexibility [7] Operational Challenges - The company's operating expenses have risen due to increasing medical care costs, with total operating costs increasing by 5.5%, 19.8%, and 12.7% year-over-year in 2023, 2024, and Q1 2025, respectively [8] - The medical care ratio (MCR) has deteriorated by 70 basis points year-over-year in Q1 2025, indicating a lower proportion of remaining premiums after claims [10]